DocGo Inc. Cash and Restricted Cash
DocGo Inc. (DCGO) had Cash and Restricted Cash of $32.17 million as of 2026-06-30, per its 10-Q filed 2026-08-17.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-08-17
- 2026-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $32.17M.
- 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $46.82M.
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $52.48M.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $77.61M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
|---|---|
| 2026-06-30 | $32.17M 10-Q · filed 2026-08-17 |
| 2026-03-31 | $46.82M 10-Q · filed 2026-05-11 |
| 2025-12-31 | $52.48M 10-Q · filed 2026-08-17 |
| 2025-09-30 | $77.61M 10-Q · filed 2025-11-10 |
| 2025-06-30 | $108.55M 10-Q · filed 2026-08-17 |
| 2025-03-31 | $103.06M 10-Q · filed 2026-05-11 |
| 2024-12-31 | $107.34M 10-Q · filed 2026-08-17 |
| 2024-09-30 | $108.58M 10-Q · filed 2025-11-10 |
| 2024-06-30 | $85.82M 10-Q · filed 2025-08-07 |
| 2024-03-31 | $58.89M 10-Q · filed 2025-05-08 |
| 2023-12-31 | $72.22M 10-K · filed 2026-03-16 |
| 2023-09-30 | $67.26M 10-Q · filed 2024-11-07 |
| 2023-06-30 | $123.76M 10-Q · filed 2024-08-07 |
| 2023-03-31 | $127.52M 10-Q · filed 2024-05-08 |
| 2022-12-31 | $164.11M 10-K · filed 2026-03-16 |
| 2022-09-30 | $179.35M 10-Q · filed 2023-11-06 |
| 2022-06-30 | $208.46M 10-Q · filed 2023-08-08 |
| 2022-03-31 | $198.72M 10-Q · filed 2023-05-09 |
| 2021-12-31 | $179.11M 10-K · filed 2025-02-27 |
| 2021-09-30 | $43.16M 10-Q · filed 2022-11-08 |
| 2021-06-30 | $36.86M 10-Q · filed 2022-08-09 |
| 2021-03-31 | $31.25M 10-Q · filed 2022-05-10 |
| 2020-12-31 | $34.46M 10-K · filed 2024-02-28 |
| 2019-12-31 | $51.77M 10-K · filed 2022-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |